Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Participation Deadline: 12/01/2026
Apply Now

Description

This study will be done in two phases, first, a feasibility study and then a registration study. In the first, feasibility will be established using the primary objectives set below. The second phase will begin no earlier than 30 days after the last patient in the initial phase has completed treatment and once safety and feasibility has been verified. The secondary objectives will serve as the objectives for the second phase of the study.